Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up Study
I‐Cheng Lee(National Yang Ming Chiao Tung University), Yi‐Hsiang Huang(First Hospital of Lanzhou University), Cheng‐Yuan Peng(China Medical University), Keng‐Hsin Lan(National Yang Ming Chiao Tung University), Chieh-Ju Lee(National Yang Ming Chiao Tung University), Han‐Chieh Lin(Taipei Veterans General Hospital), Ming‐Chih Hou(National Yang Ming Chiao Tung University), Chien‐Wei Su(National Yang Ming Chiao Tung University), Sien‐Sing Yang(Cathay General Hospital), Yuan‐Jen Wang(Taipei Veterans General Hospital)
Cited by 28
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653
Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy
|Annals of Internal Medicine|2016|364
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
|The Lancet|2014|343
Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
|Molecular and Cellular Biology|1994|284